SESSION TITLE: Cardiovascular Disease
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM
PURPOSE: Transcatheter aortic valve replacement (TAVR) was approved in 2011 in the US for replacement of the aortic valve in patients deemed inoperable due to prohibitive risk. New onset atrial fibrillation (NOAF) is a known complication of TAVR and has been associated with morbidity and mortality. We evaluated the pooled incidence of NOAF from published literature and using data from the National Inpatient Sample (NIS) database. We also evaluated the predictors of NOAF.